The Cannabinoid CB1 Receptor Antagonist AM251 Does Not Modify Methamphetamine Reinstatement of Responding

Overview

Journal Eur J Pharmacol

Specialty Pharmacology

Date 2007 Jul 14

PMID 17628534

Citations 16

Authors

Sherin Y Boctor

Joe L Martinez Jr

Wouter Koek

Charles P France

Affiliations

Soon will be listed here.

Abstract

Cannabinoid CB(1) receptor antagonists can decrease methamphetamine self-administration. This study examined whether the CB(1) receptor antagonist AM251 [N-(piperidin-1-yl)-5-(4-indophonyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide] modifies reinstatement in rats that previously self-administered methamphetamine. Rats (n=10) self-administered methamphetamine (0.1 mg/kg/infusion) under a fixed ratio 2 schedule. Non-contingent methamphetamine (0.01-1.78 mg/kg, i.v.) yielded responding for saline (reinstatement) that was similar to responding for self-administered methamphetamine. AM251 (0.032-0.32, i.v.) did not affect methamphetamine-induced reinstatement but significantly attenuated Delta(9)-tetrahydrocannabinol (2.0 mg/kg, i.p.)-induced hypothermia. These data fail to support a role for endogenous cannabinoids or cannabinoid CB(1) receptors in reinstatement and, therefore, relapse to stimulant abuse.

Citing Articles

Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets.

Yates J Subst Abuse Rehabil. 2024; 15:125-161.

PMID: 39228432 PMC: 11370775. DOI: 10.2147/SAR.S431273.

Cannabinoid CB receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats.

He X, Jordan C, Vemuri K, Bi G, Zhan J, Gardner E Acta Pharmacol Sin. 2018; 40(3):365-373.

PMID: 29967454 PMC: 6460369. DOI: 10.1038/s41401-018-0059-x.

Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.

Calik M, Carley D Sleep. 2017; 40(9).

PMID: 28934522 PMC: 5806547. DOI: 10.1093/sleep/zsx112.

Human drug discrimination: A primer and methodological review.

Bolin B, Alcorn J, Reynolds A, Lile J, Rush C Exp Clin Psychopharmacol. 2016; 24(4):214-28.

PMID: 27454673 PMC: 4965187. DOI: 10.1037/pha0000077.

Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future.

Panagis G, Mackey B, Vlachou S Front Psychiatry. 2014; 5:92.

PMID: 25132823 PMC: 4117180. DOI: 10.3389/fpsyt.2014.00092.

References

Tanda G, Munzar P, Goldberg S . Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci. 2000; 3(11):1073-4. DOI: 10.1038/80577. View

Trang T, Sutak M, Jhamandas K . Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance. Neuroscience. 2007; 146(3):1275-88. DOI: 10.1016/j.neuroscience.2007.02.031. View

de Vries T, Shaham Y, Homberg J, CROMBAG H, Schuurman K, Dieben J . A cannabinoid mechanism in relapse to cocaine seeking. Nat Med. 2001; 7(10):1151-4. DOI: 10.1038/nm1001-1151. View

Mechoulam R, Hanu L . The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection. Pain Res Manag. 2002; 6(2):67-73. DOI: 10.1155/2001/183057. View

Vinklerova J, Novakova J, Sulcova A . Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J Psychopharmacol. 2002; 16(2):139-43. DOI: 10.1177/026988110201600204. View

Pozzi O, Misiano P, Clark G, Visentin L . Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A. Pharmacology. 2003; 69(3):158-63. DOI: 10.1159/000072669. View

Anggadiredja K, Nakamichi M, Hiranita T, Tanaka H, Shoyama Y, Watanabe S . Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology. 2004; 29(8):1470-8. DOI: 10.1038/sj.npp.1300454. View

Anggadiredja K, Sakimura K, Hiranita T, Yamamoto T . Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward. Brain Res. 2004; 1021(2):272-6. DOI: 10.1016/j.brainres.2004.06.051. View

Yokel R, Pickens R . Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J Pharmacol Exp Ther. 1973; 187(1):27-33. View

10.

Takahashi R, Singer G . Self-administration of delta 9-tetrahydrocannabinol by rats. Pharmacol Biochem Behav. 1979; 11(6):737-40. DOI: 10.1016/0091-3057(79)90274-0. View

11.

Bray G . Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Intern Med. 1993; 119(7 Pt 2):707-13. DOI: 10.7326/0003-4819-119-7_part_2-199310011-00016. View

12.

Lan R, Liu Q, Fan P, Lin S, Fernando S, McCallion D . Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem. 1999; 42(4):769-76. DOI: 10.1021/jm980363y. View

13.

Lesscher H, Hoogveld E, Burbach J, van Ree J, Gerrits M . Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur Neuropsychopharmacol. 2004; 15(1):31-7. DOI: 10.1016/j.euroneuro.2004.04.003. View

14.

Yamamoto T, Anggadiredja K, Hiranita T . New perspectives in the studies on endocannabinoid and cannabis: a role for the endocannabinoid-arachidonic acid pathway in drug reward and long-lasting relapse to drug taking. J Pharmacol Sci. 2004; 96(4):382-8. DOI: 10.1254/jphs.fmj04003x5. View

15.

Cippitelli A, Bilbao A, Hansson A, Del Arco I, Sommer W, Heilig M . Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci. 2005; 21(8):2243-51. DOI: 10.1111/j.1460-9568.2005.04056.x. View

16.

Fattore L, Spano S, Cossu G, Deiana S, Fadda P, Fratta W . Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats. Neuropharmacology. 2005; 48(8):1097-104. DOI: 10.1016/j.neuropharm.2005.01.022. View

17.

Gardner E . Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav. 2005; 81(2):263-84. DOI: 10.1016/j.pbb.2005.01.032. View

18.

Yan Y, Nitta A, Mizoguchi H, Yamada K, Nabeshima T . Relapse of methamphetamine-seeking behavior in C57BL/6J mice demonstrated by a reinstatement procedure involving intravenous self-administration. Behav Brain Res. 2006; 168(1):137-43. DOI: 10.1016/j.bbr.2005.11.030. View

19.

Maldonado R, Valverde O, Berrendero F . Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006; 29(4):225-32. DOI: 10.1016/j.tins.2006.01.008. View

20.

Kroutil L, Van Brunt D, Herman-Stahl M, Heller D, Bray R, Penne M . Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. 2006; 84(2):135-43. DOI: 10.1016/j.drugalcdep.2005.12.011. View